ICOPMAP SPECIAL EDITION Mapping the trajectory of antibiotic resistance from ESBL-producing to carbapenem-resistant Enterobacteriaceae: A bibliometric study from 2000 to 2025
DOI:
https://doi.org/10.46542/pe.2025.252.103113Keywords:
Antibiotic resistance, Bibliometric analysis, Carbapenem Resistance, Enterobacteriaceae, ESBLAbstract
Background: Antibiotic resistance in Gram-negative bacteria, particularly Carbapenem-Resistant Enterobacteriaceae (CRE), is a major global health threat. The increasing prevalence of resistance mechanisms, including ESBL and carbapenemases, necessitates systematically analysing research trends.
Objective: This study aims to map global research trends on Enterobacteriaceae resistance, focusing on geographical distribution, institutional contributions, and thematic developments.
Method: A bibliometric analysis of 649 publications from PubMed (2000–2025) was conducted using VOSviewer to examine international collaborations, citation networks, and keyword co-occurrences.
Result: The United States (134 publications, 20.65%) was the most productive country, followed by China, France, and the UK. A total of 168 institutions, 194 journals, and 3,417 authors contributed to this field. Keyword analysis identified “Enterobacteriaceae” and “ESBL” as dominant terms, reflecting the focus on beta-lactam resistance.
Conclusion: Research on Enterobacteriaceae resistance is globally extensive, with major contributions from leading countries and institutions. The findings underscore the urgency of strengthening antimicrobial resistance surveillance, infection control, and novel therapeutic strategies.
References
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023). Molecular mechanisms of antibiotic resistance revisited. Nature Reviews Microbiology, 21(5), 280–295. https://doi.org/10.1038/s41579-022-00820-yv
Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews: MMBR, 74(3), 417–433. https://doi.org/10.1128/MMBR.00016-10
De Rosa, M., Verdino, A., Soriente, A., & Marabotti, A. (2021). The odd couple(s): An overview of beta-lactam antibiotics bearing more than one pharmacophoric group. International Journal of Molecular Sciences, 22(2). https://doi.org/10.3390/ijms22020617
Exner, M., Bhattacharya, S., Christiansen, B., Gebel, J., Goroncy-Bermes, P., Hartemann, P., Heeg, P., Ilschner, C., Kramer, A., Larson, E., Merkens, W., Mielke, M., Oltmanns, P., Ross, B., Rotter, M., Schmithausen, R. M., Sonntag, H. G., & Trautmann, M. (2017). Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? GMS Hygiene and Infection Control, 12, 05. https://doi.org/10.3205/dgkh000290
Jacoby, G. A. (2009). AmpC beta-lactamases. Clinical Microbiology Reviews, 22(1), 161–182. https://doi.org/10.1128/CMR.00036-08
Li, Q., Zhou, X., Yang, R., Shen, X., Li, G., Zhang, C., Li, P., Li, S., Xie, J., & Yang, Y. (2024). Carbapenem-resistant Gram-negative bacteria (CR-GNB) in ICUs: Resistance genes, therapeutics, and prevention - A comprehensive review. Frontiers in Public Health, 12, 1376513. https://doi.org/10.3389/fpubh.2024.1376513
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021). Bacterial antibiotic resistance: The most critical pathogens. Pathogens, 10(10), 1310. https://doi.org/10.3390/pathogens10101310
Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. Microbiology Spectrum, 4(2). https://doi.org/10.1128/microbiolspec.VMBF-0016-2015
Shropshire, W. C., Aitken, S. L., Pifer, R., Kim, J., Bhatti, M. M., Li, X., Kalia, A., Galloway-Peña, J., Sahasrabhojane, P., Arias, C. A., Greenberg, D. E., Hanson, B. M., & Shelburne, S. A. (2021). IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bacteraemia cohort. Journal of Antimicrobial Chemotherapy, 76(2), 385–395. https://doi.org/10.1093/jac/dkaa447
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023). Infectious diseases society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections. Clinical Infectious Diseases, 1–53. https://doi.org/10.1093/cid/ciad428
van Duin, D., & Paterson, D. L. (2020). Multidrug-resistant bacteria in the community: An update. Infectious Disease Clinics of North America, 34(4), 709–722. https://doi.org/10.1016/j.idc.2020.08.002
